Queensland Takes Bold Action on Hormone Therapy for Minors

In a significant move aimed at safeguarding children, the Queensland government has announced an immediate freeze on hormone therapy for new patients under 18. This decision follows revelations from a Cairns gender clinic, where children as young as 12 were reportedly prescribed puberty blockers without parental consent or sufficient medical oversight. The review marks a turning point in how medical treatments for transgender ideation in minors are approached, ensuring future care is guided by evidence-based practices and ethical standards.

The Catalyst for Reform

The freeze was prompted by a whistleblower’s report exposing troubling practices at the Cairns Sexual Health Service. Allegations included the provision of puberty blockers and cross-sex hormones to minors without adherence to established protocols. An investigation revealed that 42 children aged 12 to 18 had received treatment outside best practice guidelines, with 17 undergoing hormonal interventions. Alarmingly, there was insufficient parental consent and a lack of consultations with essential specialists.

Health Minister Tim Nicholls stated, “We owe it to children to ensure that care is grounded on solid evidence and that we act in this contested area with caution.” He announced a comprehensive review to scrutinize governance, care quality, and adherence to ethical standards, with an independent evaluation set to conclude by mid-2025.

Global Context and Ethical Concerns

Queensland’s move aligns with a global shift in re-evaluating puberty blockers and hormones for children. The UK’s Cass Review in 2024 and subsequent NHS decision to ban routine prescriptions of puberty blockers for minors underscore the risks of these interventions. Countries like Sweden and Finland have also imposed stricter regulations, prioritizing psychotherapy over medicalization. Critics argue that such treatments carry significant risks, including infertility and irreversible physical changes, with limited evidence of long-term mental health benefits.

Safeguarding as a Priority

The revelations from Cairns highlight the need for stringent safeguards. Parental consent and thorough medical oversight are essential when dealing with irreversible treatments. Queensland’s response demonstrates a commitment to rectifying systemic failings, addressing inconsistent standards, and ensuring future care is safe and evidence-based.

A Path Forward

The review will assess not only the Cairns clinic but also broader practices statewide. Findings will likely shape future policy, potentially serving as a model for other regions. By prioritizing transparency and accountability, Queensland has taken a significant step toward restoring trust in its healthcare system.

This freeze and review mark a victory for safeguarding, placing children’s needs at the forefront of medical decision-making. It ensures the well-being of vulnerable youth is prioritized over ideology, paving the way for ethical and evidence-based care.